Cardinal Health (CAH)

• Market cap: $30.8B
• 1 day: -0.60%
• 5 days: 4.29%
• 1 month: 9.02%
• 3 months: 12.81%
• 6 months: 31.57%
• Year to date: 6.99%
• 1 year: 19.73%
• 5 years: 134.14%
• 10 years: 54.48%
• Sector: Healthcare
• Industry: Drugs, Proprietaries & Druggists Sundries

About: Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Employees: 48,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

115% more call options, than puts

Call options by funds: $264M | Put options by funds: $123M

100% more funds holding in top 10

Funds holding in top 10: 5 [Q2] → 10 (+5) [Q3]

23% more first-time investments, than exits

New positions opened: 102 | Existing positions closed: 83

8% more capital invested

Capital invested by funds: $21.7B [Q2] → $23.3B (+$1.63B) [Q3]

0% more funds holding

Funds holding: 989 [Q2] → 992 (+3) [Q3]

3.95% less ownership

Funds ownership: 90.65% [Q2] → 86.7% (-3.95%) [Q3]

21% less repeat investments, than reductions

Existing positions increased: 326 | Existing positions reduced: 411

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $120 5% downside
• Avg. target: $134 6% upside
• High target: $145 15% upside

10 analyst ratings

• positive: 6 60%
• neutral: 4 40%
• negative: 0 0%

Citigroup Daniel Grosslight 39% 1-year accuracy 9 / 23 met price target	2% upside $129	Neutral Maintained	10 Jan 2025
TD Cowen Charles Rhyee 30% 1-year accuracy 3 / 10 met price target	14% upside $144	Buy Upgraded	8 Jan 2025
Evercore ISI Group Elizabeth Anderson 33% 1-year accuracy 11 / 33 met price target	11% upside $140	Outperform Upgraded	7 Jan 2025
B of A Securities Michael Cherny 68% 1-year accuracy 25 / 37 met price target	15% upside $145	Buy Upgraded	6 Jan 2025
Morgan Stanley Erin Wright 39% 1-year accuracy 9 / 23 met price target	8% upside $136	Overweight Maintained	17 Dec 2024